Cannabis Diversity

Next Gem and Proprietary Mutagenesis

Proven Agricultural Biotechnologies to increase cannabis diversity and the pace of new cultivar development.

Enlighten employs a suite of proprietary breeding strategies including “speed breeding” to dramatically increase the variety of strain and plant diversity while seeking cultivars with desired plant physiology “pathways” versus single markers or traits.

Our multi-disciplinary team can increase cannabis diversification faster than anyone with our high frequency 4 base non-GMO mutagenesis.

Developing more robust genetics, breeding programs and plants; high yield cannabis with desired traits and commercial applications. Proprietary IP, unique drug type germplasm, knowledge and know how in speed breeding, mutagenesis, gene editing and marker biology, plant disease and pest management.

We are creating an IP-generating ‘machine’ for the global cannabis sector!

Innovative, protective packaging.

Novel Cannabis Genetics

Proprietary Genetics Methodologies including CRISPR and MAGIC

 Enlighten’s R&D Team developed the novel gene improvement technologies for Cannabis.

Molecular Targeting

Increases breeding efficiency & improves success rates.

Targeted diversification via MAGIC breeding technologies; old growth Indica landsrace drug types bred with modern hybrids.

Genome engineering via proprietary Gene Editing and CRISPR technologies.

Both Indoor and Outdoor Cultivation.

Our proprietary breeding programs target excellence in both Cannabis and Hemp.

See the Difference!

Cannabis Analytics & AI

Advanced molecular analytics (genomic, proteomic & metabolomic)

Analytics combined with AI will supplement targeted breeding, and facilitate medical applications.

Analytical Excellence

 Enlighten’s R&D Team is exceptionally well versed in life sciences’ analytical instrumentation and performance methodologies.

Genomics, proteomics, metabolomics, gene expression, epigenetics, molecular biology, cell biology, plant biology.

Cannabinoid and Terpene testing is not standardized, with variation of 30-40% std. deviation being demonstrated.

New, more robust analytical testing methodologies are required especially those that foster standardization across the industry internationally.

We can help!